| 000 | 01657 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515054327.0 | ||
| 264 | 0 | _c20070301 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1541-7786 | ||
| 024 | 7 |
_a10.1158/1541-7786.MCR-06-0329 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcNeill, Daniel R | |
| 245 | 0 | 0 |
_aA dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents. _h[electronic resource] |
| 260 |
_bMolecular cancer research : MCR _cJan 2007 |
||
| 300 |
_a61-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 |
_aDNA Repair _xdrug effects |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aDNA-(Apurinic or Apyrimidinic Site) Lyase _xgenetics |
| 650 | 0 | 4 | _aGenes, Dominant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMethyl Methanesulfonate _xpharmacology |
| 650 | 0 | 4 |
_aOxidants _xpharmacology |
| 700 | 1 | _aWilson, David M | |
| 773 | 0 |
_tMolecular cancer research : MCR _gvol. 5 _gno. 1 _gp. 61-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1541-7786.MCR-06-0329 _zAvailable from publisher's website |
| 999 |
_c16821172 _d16821172 |
||